S.92 (Act 193)

An act relating to prescription drug price transparency and cost containment

Sponsors: Sen. Virginia Lyons, Sen. Christopher Pearson , Sen. Claire Ayer, Sen. Brian Campion, Sen. Ann Cummings, Sen. Michael Sirotkin

Last Recorded Action: 5/12/2018 - Signed by Governor on May 30, 2018

Committee Activity - Meeting Full List

2017-2018 Legislative Session
Thursday, March 2, 2017
Committee(s):
Senate Committee on Health and Welfare
11:00 AM

S.92 - An act relating to prescription drug price transparency and cost containment

Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Nancy Hogue, Director of Pharmacy Services, Department of Vermont Health Access (DVHA)
Charles Storrow, Express Scripts, Inc.
Bonita Libman, Professor of Medicine, University of Vermont Medical Center
Jessa Barnard, General Counsel and Vice-President for Policy, Vermont Medical Society
Thomas Felix, Medical Director, R& D Policy, Amgen
Tuesday, March 14, 2017
Committee(s):
Senate Committee on Health and Welfare
-

S.92 - An act relating to prescription drug price transparency and cost containment

Jason Williams, Director of Government and Community Relations, University of Vermont Medical Center
Wednesday, March 15, 2017
Committee(s):
Senate Committee on Health and Welfare
10:15 AM

S.92 - An act relating to prescription drug price transparency and cost containment

Brian Murphy, Director of Vendor Management, Blue Cross/Blue Shield of Vermont
Matt McMahon, Lobbyist, McLean, Meehan & Rice
Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Friday, March 17, 2017
Committee(s):
Senate Committee on Health and Welfare
8:00 AM

S.92 - An act relating to prescription drug price transparency and cost containment

Vote

Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Thursday, March 30, 2017
Committee(s):
House Committee on Health Care
3:15 PM

S.92 - An act relating to prescription drug price transparency and cost containment

Walk-through

Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Friday, March 16, 2018
Committee(s):
House Committee on Health Care
1:00 PM

S.92 - An act relating to prescription drug price transparency and cost containment

Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Tuesday, April 3, 2018
Committee(s):
House Committee on Health Care
1:00 PM

S.92 - An act relating to prescription drug price transparency and cost containment

Jessa Barnard, Executive Director, Vermont Medical Society
Brian Murphy, Director of Vendor Management, Blue Cross/Blue Shield of Vermont
Jim McKay, Director of Clinical Development and Medical Affairs, Sandoz
Carrie Phillips, Executive Officer, Vermont Board of Pharmacy
Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Matt McMahon, Lobbyist, McLean, Meehan & Rice
Susan Gretkowski, Senior Government Affairs Strategist, MVP Healthcare
Friday, April 13, 2018
Committee(s):
House Committee on Health Care
1:40 PM

S.92 - An act relating to prescription drug price transparency and cost containment

Review new draft of bill and vote

Rep. Lori Houghton
Rep. Benjamin Jickling, House Committee on Health Care
Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Friday, April 20, 2018
Committee(s):
Senate Committee on Health and Welfare
9:00 AM

S.92 - An act relating to prescription drug price transparency and cost containment

Review House Amendment

Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Wednesday, April 25, 2018
Committee(s):
Senate Committee on Health and Welfare
8:30 AM

S.92 - An act relating to prescription drug price transparency and cost containment

Rep. Lori Houghton, House Committee on Health Care
Rep. William J. Lippert, House Committee on Health Care
Jeff Hochberg, President, Vermont Retail Druggists
Jamie Feehan, Lobbyist, CVS/Caremark
Bridget Morris, Lobbyist, Association of Accessible Medicine
Nancy Hogue, Director of Pharmacy Services, Department of Vermont Health Access (DVHA)
10:00 AM

S.92 - An act relating to prescription drug price transparency and cost containment

Continued Testimony and Committee Discussion

Susan Gretkowski, Senior Government Affairs Strategist, MVP Healthcare
Jeff Hochberg, President, Vermont Retail Druggists
Georgia Maheras, Director, Vermont Public Policy, Bi-State Primary Care Association
Thursday, April 26, 2018
Committee(s):
Senate Committee on Health and Welfare
8:30 AM

S.92 - An act relating to prescription drug price transparency and cost containment

Proposed Amendment

Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Jamie Feehan, Lobbyist, CVS/Caremark
Rep. Lori Houghton, House Committee on Health Care
Thursday, April 26, 2018
Committee(s):
House Committee on Health Care
9:40 AM

S.92 - An act relating to prescription drug price transparency and cost containment

Update, Senate actions

Rep. Lori Houghton
Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Friday, April 27, 2018
Committee(s):
Senate Committee on Health and Welfare
9:30 AM

S.92 - An act relating to prescription drug price transparency and cost containment

Proposed Amendment

Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Wednesday, May 2, 2018
Committee(s):
House Committee on Health Care
10:00 AM

S.92 - An act relating to prescription drug price transparency and cost containment

Committee discussion, changes to various bills from the Senate; others as needed

Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Nolan Langweil, Senior Fiscal Analyst, Joint Fiscal Office
Thursday, May 3, 2018
Committee(s):
House Committee on Health Care
9:30 AM

S.92 - An act relating to prescription drug price transparency and cost containment

Review changes; other bills as needed

Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Stephanie Barrett, Associate Fiscal Officer, Joint Fiscal Office
1:00 PM

S.92 - An act relating to prescription drug price transparency and cost containment

Committee Discussion; further amendment to S.203; vote on S.224.